德克萨斯州沃斯堡 - 专注于外科和伤口护理医疗技术的Sanara MedTech Inc. (NASDAQ: SMTI)今日宣布，James "Jim" Stuckert先生已从公司董事会辞职。Stuckert先生将在离职后继续担任名誉董事。Keith Myers先生已被任命填补董事会的空缺。 Sanara执行主席兼首席执行官Ron Nixon对Stuckert先生多年来的服务和对公司发展的贡献表 ...

Based in Fort Worth, Texas, (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving ...

Higher costs continue to pressure profit margins: The cost of MedTech's inputs have risen, with factors such as inflation and ...

MD+DI Senior Editor Amanda Pedersen calls on investors, industry leaders, and policymakers to prevent the collapse of the medtech ecosystem as we know it.

SymPhysis Medical, a Galway medical technology firm focused on palliative care for late-stage cancer patients, has raised a ...

Galway MedTech company SymPhysis Medical has secured €2.2m funding for the development of a device to address the condition ...

Bellevue Asset Management’s Medtech & Services Fund has successfully combined stability and diversification during the past ...

总部位于德克萨斯州的骨科、假肢和外科器械及用品专业公司Sanara MedTech Inc.与其首席执行官Ronald T. Nixon签订了新的雇佣协议，这一消息在最近的SEC文件中披露。 该协议自2024年9月1日生效，概述了Nixon的薪酬，包括35万美元的基本工资、股票和现金奖金的资格，以及离职条款。 Nixon此前担任执行主席，于2024年5月12日被董事会任命为首席执行官。这份雇佣合同 ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

The government is considering tweaking regulatory norms for MedTech and pharma sectors and sought industry inputs for the ...

Healthium Medtech, a global player in medical devices, focused on products in surgical and post-surgical ecosystem including ...

BioBridges said its medtech division will help companies bring products to market efficiently and effectively.